Original Research
Published on 09 Jul 2020
A Peptide-Based PD1 Antagonist Enhances T-Cell Priming and Efficacy of a Prophylactic Malaria Vaccine and Promotes Survival in a Lethal Malaria Model
in Vaccines and Molecular Therapeutics

- 4,217 views
- 5 citations













